Down syndrome, severe psoriasis, and increased risk for cardiovascular events. [electronic resource]
Producer: 20200610Description: 31-33 p. digitalISSN:- 1547-1896
- Administration, Cutaneous
- Adrenergic beta-Antagonists -- therapeutic use
- Anti-Inflammatory Agents -- therapeutic use
- Down Syndrome -- complications
- Fatal Outcome
- Female
- Heart Septal Defects -- complications
- Humans
- Hyperlipidemias -- complications
- Hypolipidemic Agents -- therapeutic use
- Interferon-gamma -- immunology
- Metoprolol -- therapeutic use
- Middle Aged
- Myocardial Infarction -- complications
- Polycythemia -- complications
- Psoriasis -- complications
- Risk Factors
- Severity of Illness Index
- Simvastatin -- therapeutic use
- Triamcinolone Acetonide -- therapeutic use
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.